Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis

Diabetes

Volumn 48, Issue 5, 1999, Pages 1082-1087

  Hardin, Dana S ^a,c,d   LeBlanc, Adrian ^b   Para, Laurie ^c   Seilheimer, Dan K ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Department of Pediatrics   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; ENERGY EXPENDITURE; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID OXIDATION; LIPOGENESIS; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CALORIMETRY, INDIRECT; CYSTIC FIBROSIS; DEUTERIUM; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; LIVER; MALE; OXIDATION-REDUCTION;

EID: 0032934521     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.5.1082     Document Type: Article

References (46)

1. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu SC, Klein DJ: Diabetes mellitus associated with cystic fibrosis. J Pediatr 112:373-377, 1988
2. Andersen O, Garne S, Heilmann C, Petersen KE, Petersen W, Koch C: Glucose tolerance and insulin receptor binding to monocytes and erythrocytes in patients with cystic fibrosis. Acta Paediatr Scand 77:67-71, 1988
3. Wilmshurst EG, Soeldner S, Holsclaw DS, Kaufmann RL, Shwachman H, Aoki TT, Gleason RE: Endogenous and exogenous insulin responses in patients with cystic fibrosis. Pediatrics 55:75-82, 1975
4. Moran A, Diem P, Klein D, Levitt MD, Robertson RP: Pancreatic endocrine function in cystic fibrosis. J Pediatr 118:715-723, 1991
5. Austin A, Kalhan SC, Orenstein D, Nixon P, Arslanian S: Roles of insulin resistance and β-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab 79:80-85, 1994
6. Moran A, Pyzdrowski KL, Weinreb J, Kahn BB, Smith SA, Adams KS, Seaquist ER: Insulin sensitivity in cystic fibrosis. Diabetes 43:1020-1026, 1994
7. Hardin DS, LeBlanc A, Lukenbaugh S, Seilheimer DK: Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 6:948-856, 1997
8. DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in non-insulin-dependent-diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-395, 1989
9. DeFronzo RA, Simonson D, Ferrannini E: Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23:313-319, 1982
10. Felber JP, Ferrannini E, Golay A, Meyer HU, Theibaud D, Curchod B, Maeder E, Jequier E, DeFronzo RA: Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-1350, 1987
11. Kien CL, Horswill CA, Zipf WB, McCoy KS, O'Dorisio T: Elevated hepatic glucose production in children with cystic fibrosis. Pediatr Res 37:600-605,1995
12. Thiebaud D, Jacot E, DeFronzo RA, Maeder E, Jequier E, Felber J: The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 31:957-963, 1982
13. Marchesini G, Pacini G, Bianchi GP, Patrono D, Cobelli C: Glucose disposal, beta-cell secretion and hepatic insulin extraction in cirrhosis: a minimal model assessment. Gastroenterology 99:1715-1722, 1990
14. Collins JR, Crofford OB: Glucose intolerance and insulin resistance in patients with liver disease. Arch Intern Med 124:142-148, 1969
15. Shepherd R, Cooksley WG, Cooke WD: Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis. J Pediatr 97:351-357, 1980
16. Hardin DS, LeBlanc A, Lukenbaugh S, Para L, Seilheimer DK: Proteolysis associated with insulin resistance in cystic fibrosis. Pediatrics 101:433-437, 1998
17. Zemel BS, Kawchak DA, Cnaan A, Zhao H, Scanlin TF, Stallings VA: Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function, and genotype in children with Cystic Fibrosis. Pediatr Res 40: 578-586, 1996
18. Thomson MA, Wilmott RW, Wainwright C, Masters B, Francis PJ, Shepherd RW: Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis. J Pediatr 129:367-373, 1996
19. Hellerstein MK, Grunfeld C, Wu K, Christiansen M, Kaempfer S, Kletke C, Shackleton CH: Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab 76:559-565, 1998
20. Flatt JP: The biochemistry of energy expenditure. Rec Adv Obes Res 2:211, 1978
21. Volovitz B, Amir J, Malik H, Kauschansky A, Varsano I: Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide. N Engl J Med 329:1703-1708, 1993
22. Zeitlin S, Wood P, Evans A, Radtord M: Overnight urine growth hormone, cortisol and adenosine 3′ 5′ cyclic monophosphate excretion in children with chronic asthma treated with inhaled beclomethasone dipropionate. Respir Med 87:445-448, 1993
23. Kiviranta K, Turpeinen M: Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma Thorax 48:974-978, 1993
24. Hardin DS, Azzarelli B, Edwards J, Wigglesworth J, Maianu L, Brechtel G, Johnson A, Baron A, Garvey WT: Mechanisms of enhanced insulin sensitivity in endurance-trained athletes. J Clin Endocrinol Metab 80:2437-2446, 1995
25. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
26. Spector E, LeBlanc A, Shackelford L: Hologic QDR 2000 whole-body scans: a comparison of three combinations of scan modes and analysis software. Osteoporos Int 5:440-445, 1995
27. Jensen MD, Kanaley JA, Roust LR, O'Brien PC, Braun JS, Dunn WL, Wahner HW: Assessment of body composition with use of dual-energy X-ray absorptiometry: evaluation and comparison with other methods. Mayo Clin Proc 68:867-873, 1993
28. DeFronzo RA, Jacot E, Jequier E, Maeder E, Feller JP: The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30:1000-1007, 1981
29. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Diabetes 36:914-924, 1987
30. Simonson DC, DeFronzo RA: Indirect calorimetry: methodological and interpretative problems. Am J Physiol 258:E399-E412, 1990
31. Golay A, DeFronzo RA, Ferrannini E, Simonson DC, Thorin D, Acheson K, Thiebaud D, Curchod B, Jequier E, Felber JP: Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31:585-591, 1988
32. Morgan CR, Lazaro A: Immunoassay of insulin: two antibody system: plasma insulin levels in normal, subdiabetic and diabetic rats. Diabetes 12:115-126, 1963
33. Steele R: Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420-430, 1959
34. Meyer HU, Curchod B, Maeder E, Pahud P, Jequier E, Felber P: Modifications of glucose storage and oxidation in non-obese diabetics, measured by continuous indirect calorimetry. Diabetes 29:752-756, 1980
35. Ferrannini E, Smith JD, Cobelli C, Toffolo G, Pilo A, DeFronzo R: Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest 76:357-364, 1985
36. Cobelli C, Bier DM, Ferrannini E: Modeling glucose metabolism in man: theory and practice. Horm Metab Res 24 (Suppl.): 1-10, 1990
37. Rizza RA, Mandarino LJ, Gerich JE: Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 240:E630-E639, 1981
38. Wolfe RR: Radioactive and Stable Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis. New York, Wiley-Liss, 1992, p. 283-315
39. Rao RH: Adaptations in glucose homeostasis during chronic nutritional deprivation in rats: hepatic resistance to both insulin and glucagon. Metabolism 44:817-824, 1995
40. Lewis GF, Zinman B, Groenewoud Y, Vranic M, Giacca A: Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45:454-462, 1996
41. Stevenson RW, Williams PE, Cherrington AD: role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog. Diabetologia 30:782-790, 1987
42. Lanng S: Glucose intolerance in cystic fibrosis. Dan Med Bull 44:23-39, 1997
43. Plat L, Byrne MM, Sturis J, Polonsky KS, Mockel J, Fery F, Van Cauter E: Effects of morning cortisol elevation on insulin secretion and glucose regulation in humans. Am J Physiol 270:E36-E42, 1996
44. Hother-Nielsen O, Beck-Nielsen H: Insulin resistance but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus. Acta Endocrinol 124:637-645, 1991
45. Beck-Nielsen H, Hother-Nielsen O, Vaag A, Alford F: Pathogenesis of type-2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment. Diabetologia, 37:217-221, 1994
46. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M: Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 77:956-962, 1993